News

Study Assess Current Recommended Guidelines for the Treatment of PV Patients

MPN News | October 31, 2018
Read More

University of Michigan seeks to make bone marrow imaging less painful for people with myeloproliferative neoplasms

MPN News | October 23, 2018

Patients with an MPN are invited to participate in the non-invasive study

Read More

Ropeginterferon reduces JAK2 burden compared to Hydroxyurea in PV according to new study

MPN News | October 15, 2018

After 1 year of treatment with ropeginterferon, the ratio of JAK2-mutated to wild-type colonies grown from bone marrow progenitors was reduced by 64%, compared to 25% in patients receiving hydroxyurea.

Read More

Classification and Prognostic Models Developed for MPN Patient Outcomes

MPN News | 10/11/18
Read More

Increased Pentraxin-3 Correlates with the Activity of the Neoplastic Clone in Primary Myelofibrosis

MPN News | December 7, 2017

Increased Pentraxin-3 Correlates with the Activity of the Neoplastic Clone in Primary Myelofibrosis

Read More

FDA awards $18 million in grants for advancing treatment of rare diseases

MPN News | 10/3/18

The FDA announced on that they have awarded 12 new clinical trial research grants toward advancing the development of treatments of rare diseases.

Read More

Behind the Mystery: Living with Polycythemia Vera

MPN News

MPN experts Dr. Richard T. Silver, from New York - Presbyterian/Weill Cornell Medical Center, and Dr. Srdan Verstovsek of the MD Anderson Cancer Center, to discuss the latest in patient care and clinical trials for polycythemia vera, as well as the future for those living with PV as a chronic illness.

Read More

Janssen Elects Not to Continue Agreement with Geron for Imetelstat

MPN News

Today Janssen announced that they would no longer be partnering with Geron on the development of Imetelstat

Read More

MPN Research Foundation Attends 3rd Annual MPN Horizons Conference

MPN News | September 11, 2018

Director of Development, Bill Crowley, and Executive Director, Michelle Woehrle, represented MPN Research Foundation at the recent MPN Horizons 2018 Conference in Prague, Czech Republic.

Read More

MPN Research Foundation's SCT Spectrum Transplant Timing Tool featured in CURE Today

MPN News | August 20, 2018
Read More

Recent Study Indicates a Familial Predisposition for MPN

MPN News | August 15 , 2018

A recent analysis of the Swedish Cancer Family Database has found that there is a familial predisposition for certain blood cancers, including myeloproliferative neoplasms.

Read More

MPN Research Foundation's Patient Registry Featured in CURE Today.

MPN News | July 23, 2018

Registry Manager, Lindsey Whyte, discusses the benefits that myMPN brings to MPN patients and researchers with CURE Today.

Read More

MPN Research Foundation Launches Stem Cell Transplant Timing Tool for MPN Patients

MPN News | July 19, 2018

The goal of the SSTT tool is to increase successful stem cell transplant outcomes by decreasing the number of delayed transplant for MPN patients.

Read More

Dr. Ruben Mesa Featured in Rare Diseases Report Magazine

MPN News | June 26, 2018

Dr. Mesa discusses updates on emerging innovations, his views about the greatest obstacles facing the treatment of rare diseases & his support for the working as a team when treating MPNs

Read More

Interferon Changes Life of Essential Thrombocythemia Patient, Karrie Schwartz

MPN News | June 25, 2018

Stories like Karrie's are the reason MPNRF is dedicated to investing time and resources into opportunities for repurposing existing drugs and figuring out the mechanisms of action that lead to results.

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?